Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Donovan

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
Science (New York, N.Y.)|March 12, 2005
High-throughput mapping of a dynamic signaling network in mammalian cellsMiriam Barrios-Rodiles, Kevin R Brown, Barish Ozdamar, et al.
Science Translational Medicine|January 29, 2016
Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humansGissette Reyes-Soffer, Byoung Moon, Antonio Hernandez-Ono, et al.
Stroke|January 24, 2013
Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovaleDavid E Thaler, Robin Ruthazer, Emanuele Di Angelantonio, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 14, 2012
The risk of paradoxical embolism (RoPE) study: initial description of the completed databaseDavid E Thaler, Emanuele Di Angelantonio, Marco R Di Tullio, et al.
Journal of Lipid Research|March 19, 2017
Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and EJohn S Millar, Michael E Lassman, Tiffany Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2022
Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)Heidi S Donovan, Susan M Sereika, Lari B Wenzel, et al.
The Journal of Clinical Investigation|April 2, 2016
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjectsJohn S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.
The Journal of Clinical Investigation|May 12, 2015
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjectsJohn S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2016
Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer ProteinGissette Reyes-Soffer, John S Millar, Colleen Ngai, et al.
Plos One|November 19, 2019
Barriers to integration of bioinformatics into undergraduate life sciences education: A national study of US life sciences faculty uncover significant barriers to integrating bioinformatics into undergraduate instructionJason J Williams, Jennifer C Drew, Sebastian Galindo-Gonzalez, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Science (New York, N.Y.)|March 12, 2005
High-throughput mapping of a dynamic signaling network in mammalian cellsMiriam Barrios-Rodiles, Kevin R Brown, Barish Ozdamar, et al.
Science Translational Medicine|January 29, 2016
Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humansGissette Reyes-Soffer, Byoung Moon, Antonio Hernandez-Ono, et al.
Stroke|January 24, 2013
Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovaleDavid E Thaler, Robin Ruthazer, Emanuele Di Angelantonio, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 14, 2012
The risk of paradoxical embolism (RoPE) study: initial description of the completed databaseDavid E Thaler, Emanuele Di Angelantonio, Marco R Di Tullio, et al.
Journal of Lipid Research|March 19, 2017
Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and EJohn S Millar, Michael E Lassman, Tiffany Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2022
Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)Heidi S Donovan, Susan M Sereika, Lari B Wenzel, et al.
The Journal of Clinical Investigation|April 2, 2016
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjectsJohn S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.
The Journal of Clinical Investigation|May 12, 2015
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjectsJohn S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2016
Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer ProteinGissette Reyes-Soffer, John S Millar, Colleen Ngai, et al.
Plos One|November 19, 2019
Barriers to integration of bioinformatics into undergraduate life sciences education: A national study of US life sciences faculty uncover significant barriers to integrating bioinformatics into undergraduate instructionJason J Williams, Jennifer C Drew, Sebastian Galindo-Gonzalez, et al.
Pageof 18